PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “cervical screening”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources

Women's knowledge and experience of cervical screening: a failure of health education and medical organization.

A survey of the knowledge of and attitudes towards cervical cytology screening in various locations in Tower Hamlets showed that 77 per cent of women in the sample reported that they had a smear test, and 86 per cent knew about them, although a small group of active elderly were unlikely to know much about the test or to have had one. Only 11 per cent of the 600 women under 65 understood that cervical cytology was to prevent cancer, whereas 71 per cent thought that it was to detect cancer. Of the 205 women who recalled their experience of the test, all had some difficulty. Two-thirds were embarrassed, and 54 per cent had pain or discomfort, which included all those women who did not feel embarrassed. Forty-three per cent had been informed of the result of their tests and about one-quarter of those took steps to get the result. Seventy-one per cent of the women had had their first test done before the age of 35, but only 9 per cent after the age of 45. A quarter of those screened had only had one test done. The women considered that more publicity about the test, the knowledge that a woman doctor would do the test, and more encouragement by health professionals would be improvements most likely to increase the uptake of screening. The possibility of a service offering immediate results should be explored by means of a pilot study.

Female↗

Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.

The management of women with a smear read as borderline/mild dyskaryosis (BMD) found by cervical cancer screening is still under discussion as only few of these cases are associated with high-grade lesions. To determine the optimal screening strategy for these women, a simulation model of cervical cancer development was used that is based on high-risk human papillomavirus (hrHPV) infection. The current strategy of repeat cytological testing at 6 and 18 months after BMD was compared to strategies with adjunct hrHPV testing. Calculations were done for both conventional and liquid-based cytology as the primary screening tool. In comparison to current screening, adjunct hrHPV testing was more effective in preventing cancer and more woman-friendly (reduction in colposcopy referrals with outcome < cervical intraepithelial neoplasia (CIN2) of up to 56% and in repeat smears of 30-100%). In combination with conventional cytology, cost-effective strategies were the ones in which a sample for high-risk human papillomavirus (hrHPV) testing is collected at a return visit within 1 month or in which hrHPV testing is restricted to repeat smears taken at 6 and 18 months. For these strategies, co-collection of samples for hrHPV testing at baseline is not necessary which has organizational and cost advantages. In combination with liquid-based cytology, it was cost-effective to perform a reflex hrHPV test at baseline from the liquid-based specimen. Liquid-based screening was more effective than conventional screening, but annual diagnosis costs were euro5 million higher (population size 16 million). In conclusion, our calculations indicate that implementation of hrHPV testing for the management of women with borderline or mild dyskaryosis (BMD) is feasible both in settings where conventional and liquid-based cytology is current practice.

Adult↗

Screening for cervical neoplasia in an unselected rural Guatemalan population using direct visual inspection after acetic acid application: a pilot study.

OBJECTIVE: To assess the acceptability of cervical screening using direct visual inspection after acetic acid application followed by immediate cryotherapy for cervical intraepithelial neoplasia among women in rural Guatemala. MATERIALS AND METHODS: An unselected group of 1,052 women voluntarily registered to undergo cervical screening using direct visual inspection of the cervix after acetic acid application. Women with acetowhite changes consistent with cervical intraepithelial neoplasia were offered immediate cryotherapy. RESULTS: Cervical screening was deferred in 80 (7.6%) registrants, and 18 (1.7%) refused to undergo an examination. Among the 954 registrants screened, 125 (13%) had findings consistent with cervical intraepithelial neoplasia. Cryotherapy was deferred in three patients. A total of 121 (99%) women agreed to immediate cryotherapy. CONCLUSION: Direct cervical visualization after acetic acid application followed by immediate cryotherapy for acetowhite changes consistent with cervical intraepithelial neoplasia would be a well-accepted method of cervical screening in rural Guatemala.

Acetic Acid↗

Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.

BACKGROUND: The incidence of adenocarcinoma of the cervix did not decline in Western countries in the 1970s and 1980s despite the availability and use of cervical cytologic screening. The impact of improved endocervical sampling and better recognition of the cytologic precursors to adenocarcinoma during the 1990s in reducing the risk of adenocarcinoma is currently unknown. METHODS: Using records from a statewide registry, the authors compared the screening histories of 160 women with adenocarcinoma (33 microinvasive cases and 127 invasive cases) who were diagnosed between 1995 and 2001 with the screening histories of 640 control women in a matched case-control study. RESULTS: A decreased risk of invasive adenocarcinoma was associated with a recent negative Papanicolaou (Pap) smear and at least one smear with an endocervical component since 1994. An increased risk of invasive adenocarcinoma was associated with a history of previous cervical abnormalities and greater than 5 years between Pap smears. There was no significant difference between cases and controls with regard to the number of negative Pap smears. There was little apparent difference in the screening histories of patients with microinvasive tumors and the controls, with the control women appearing to have no greater relative protection than the cases. With biennial screenings, the authors estimate that a 46% reduction in the cumulative incidence of invasive adenocarcinoma could be achieved, and with annual screening, a 65% reduction could be achieved. CONCLUSIONS: The incidence of cervical adenocarcinoma should begin to decline in the current decade among screened women.

Adenocarcinoma↗

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.

OBJECTIVE: This is a meta-analysis of studies comparing HPV testing to cytology with regard to their accuracy in the detection of underlying high grade cervical intraepithelial neoplasia in primary cervical cancer screening. METHODS: A systematic review was conducted following the Cochrane Collaboration Guidelines. A systematic search was performed in 8 electronic databases. Strict selection criteria were applied in terms of types of participants, types of interventions and methods to limit verification bias. Where possible we calculated the sensitivity, specificity, positive and negative predictive value of cytology and the HPV test, as well as sensitivity and specificity ratios for the detection of CIN2 or worse. Random effect models were used for pooling accuracy parameters. The results were displayed using forest plots. RESULTS: We identified 25 studies fulfilling the inclusion criteria. The pooled sensitivity of HC2, PCR, cytology (ASCUS or worse) and cytology (LSIL or worse) was 90%, 80.9%, 72.7% and 61.6%, respectively, and the pooled specificity was 86.5%, 94.7%, 91.9% and 96.0%, respectively. The ratio of the sensitivity of HC2 to cytology (ASCUS) was 1.25 (95% CI=1.20-1.29), and the corresponding specificity ratio was 0.97 (95% CI=0.96-0.98). The ratio of the sensitivity of combination of HC2 and cytology (ASCUS) to HC2 alone was 1.05 (95% CI=1.04-1.06) and the ratio of the specificity 0.95 (95% CI=0.94-0.96). For women over 30 years, the sensitivity of HC2 was 94.8% and the specificity 86.0%. CONCLUSIONS: Compared to cytology, the HC2 and PCR are substantially more sensitive for prevalent CIN2 or worse but significantly less specific. The combination of HC2 and cytology has the highest sensitivity and lowest specificity. However, reduction of the incidence of or mortality from invasive cervical cancer among HPV screened subjects compared to cytologically screened subjects has not yet been demonstrated.

Female↗

Improving the quality of cervical screening.

OBJECTIVE: To compare the adequacy of cervical cytology sampling by a newly designed cervical cell sampler (the implement) with a commonly used, extended tip cervical scraper, namely the Jordan's spatula, by assessing the quality of cervical smears obtained. DESIGN: Prospective randomised controlled trial, with the approval of the local Ethics Committee after informing the Medical Devices Agency in the UK. SETTING: Colposcopy Clinic in a District General NHS Trust Hospital in London. POPULATION: Women attending the Colposcopy Clinic and having a good command of the English language (to avoid any misinterpretation of the information and enabling them to give informed consent) were invited to take part. Two hundred and twenty patients were recruited. METHODS: The women were randomised into two groups, each of them having two smears at the same time, half of them having their first smear with the Jordan's spatula and the other half having the first smear with the new implement. MAIN OUTCOME MEASURE: Good quality smears, assessed by evidence of effective sampling of the transformation zone, including immature metaplastic cells and also endocervical cells. RESULTS: Fifty-four percent of smears taken by the new implement showed good quality smears, compared with 37% taken by Jordan's spatula, a statistically significant result with P value <0.001. CONCLUSION: A larger number of good quality smears, judged by evidence of sampling of transformation zone and presence of endocervical cells, were obtained with the new implement. The difference was statistically significant. This would enhance the ability to detect dyskaryosis and increase adequate smear rates, reducing unnecessary recall of patients for repeat smears.

Colposcopy↗

[Flow cytofluorometric analysis for screening cervical squamous cell carcinoma using specific antibody to a tumor antigen TA-4].

The clinical value of flow cytometric analysis using a specific antibody to a tumor antigen TA-4 was studied in patients with cervical squamous cell carcinoma. Exfoliative cells of the uterine cervix were stained by the indirect immunofluorescent technique using an anti-serum to TA-4 (rabbit) and FITC-labeled anti-rabbit gammaglobulin, and applied to FCM. Patterns of TA-4 histogram were divided into 3 groups. Type I; A single peak at the area of low fluorescence intensity. Type II; A single peak at the area of higher fluorescence intensity (50-80th channel). Type III; Two peaks, one with the low fluorescence intensity and the other with the higher fluorescence intensity (50-80th channel). Of 35 patients with non-malignant subjects 30 patients (85.7%) showed the Type I pattern and 20(87.0%) of 23 patients with cervical squamous cell carcinoma showed Type II or Type III pattern. It was concluded that this method would be useful for automated cytology in screening for cervical squamous cell carcinoma.

Antigens, Neoplasm↗

Factors affecting cervical screening uptake in prisoners.

Imprisoned women are at increased risk of cervical cancer but less likely to have been screened for this disease. There is very little information on the situation in prisons in the UK but this study indicates that, as anticipated, these women are less likely to have been screened in the last five years than women generally. Whilst there are no ethnic differences, it appears that women who had been in prison longer than three months were more likely to have had a smear in the last five years compared with those who had been in for three months or less (79.2% vs 37.5%, Chi-squared=9.7, p=0.002) suggesting that the prison health services had been able to use this opportunity to screen this disadvantaged population.

England↗

The effectiveness of cervical screening: a population-based case-control study.

The cervical smear histories of 36 women with invasive cervical cancer were compared to those of 120 age-matched controls, drawn from local registrar's offices. Of the cases 47% were screened at least once, while for the controls this figure was 68%. The relative risk of getting invasive cervical cancer for women screened at least once compared to women who were never screened was 0.32. The most important confounding factor was age at first intercourse. Contrary to other studies however, it was found that women who were younger when having first intercourse were screened more often. After correcting the relative risk of screened vs unscreened for age at first intercourse, the relative risk became 0.22. When the length of the interval since the last smear was considered, the relative risk was 0.18 when the smear was made between 2 and 5 years earlier and 0.30 when this smear was made more than 5 years earlier. These results support the assumption that screening is effective in the prevention of invasive cancer of the uterine cervix. Even a screening interval of more than 5 years provides considerable protection.

Adult↗

Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs.

Our objective was to review current large studies of human papillomavirus (HPV) DNA testing as an adjunct to the Papanicolaou test for cervical cancer screening programs. We analyzed 10 large screening studies that used the Hybrid Capture 2 test and 3 studies that used the polymerase chain reaction test in a manner that enabled reliable estimates of accuracy for detecting or predicting high-grade cervical intraepithelial neoplasia (CIN). Most studies allowed comparison of HPV DNA and Papanicolaou testing and estimates of the performance of Papanicolaou and HPV DNA as combined tests. The studies were selected on the basis of a sufficient number of cases of high-grade CIN and cancer to provide meaningful statistical values. Investigators had to demonstrate the ability to generate reasonably reliable Hybrid Capture 2 or polymerase chain reaction data that were either minimally biased by nature of study design or that permitted analytical techniques for addressing issues of study bias to be applied. Studies had to provide data for the calculation of test sensitivity, specificity, predictive values, odds ratios, relative risks, confidence intervals, and other relevant measures. Final data were abstracted directly from published articles or estimated from descriptive statistics presented in the articles. In some studies, new analyses were performed from raw data supplied by the principal investigators. We concluded that HPV DNA testing was a more sensitive indicator for prevalent high-grade CIN than either conventional or liquid cytology. A combination of HPV DNA and Papanicolaou testing had almost 100% sensitivity and negative predictive value. The specificity of the combined tests was slightly lower than the specificity of the Papanicolaou test alone, but this decrease could potentially be offset by greater protection from neoplastic progression and cost savings available from extended screening intervals. One "double-negative" HPV DNA and Papanicolaou test indicated better prognostic assurance against risk of future CIN 3 than 3 subsequent negative conventional Papanicolaou tests and may safely allow 3-year screening intervals for such low-risk women.

Cervix Uteri↗

Women's perspectives on cervical screening and treatment in developing countries: experiences with new technologies and service delivery strategies.

This review of studies conducted by partners in the Alliance for Cervical Cancer Prevention (ACCP) examines women's perspectives on, and acceptability of, new cervical cancer screening and treatment approaches, management by mid-level staff, single-visit strategies, treatment side effects, and post-treatment abstinence requirements in low-resource settings. All screening, managed by female nurses and irrespective of method or constellation of methods, appeared to be highly acceptable. Similarly, cryotherapy treatment, including cryotherapy managed by nurses immediately after screening, was well-received by women in the studies. Minor side effects, although rather prevalent, and difficulties with post-treatment abstinence, did not appear to significantly deter women from recommending the procedure to friends. Rather, a sense of relief was evident, a feeling that it was better to be treated than not treated, and better to be treated sooner rather than later. While full replication may not be possible, this does not lessen the fact that screening and treatment in developing countries, even with new technologies, immediate treatment and even using mid-level providers, can be very acceptable to women if provided in a safe, caring and preferably all-female environment.

Adult↗

Reasons for non-attendance for computer-managed cervical screening: pilot interviews.

A pilot interview study looked at reasons why women did not attend a clinic following an invitation for a cervical smear test offered via a computer-managed scheme. Three broad issues were identified. First, the inaccuracy of the computer database (the FPC register) meant some women were inaccessible because they no longer lived at the address recorded. Other women were ineligible or unsuitable within the criteria of the scheme but had been sent invitations inappropriately because their screening records were incomplete or out of date. Second, aspects of service organisation and provision led to misclassification of some attenders as non-attenders and to various failures of communication such as non-receipt of the invitation or health education leaflet or unsuccessful attempts to rearrange appointments. In addition, the appointment or venue offered could be unsatisfactory. The third issue concerned the characteristics of the women which sometimes interacted with practical problems connected with service provision. Other women believed the test to be inappropriate for themselves while some were deterred by the prospect of the test itself. In general, embarrassment was pervasive and reflected in preferences for different types of service provision. Women who had neither attended nor been otherwise tested were particularly likely to express feelings of fear and fatalism. General attitudes to the test were favourable but this was not always applied personally. A typology of reasons for non-attendance for computer-managed cervical screening is presented.

Attitude to Health↗

Can flow cytometry reduce the workload for cervical screening? The results of a series of 622 specimens.

A simple method permitting the flow cytometric examination of cervical specimens has been developed and an assessment made of the feasibility of relying on this method to screen women for cervical neoplasia. Examination of four flow cytometric parameters showed differences between morphologically normal and abnormal specimens and allowed identification of a proportion of the normal specimens. The system had a false negative rate of 8%. Our experience with cervical specimens has revealed a number of problems associated with their examination by flow cytometry and these are discussed.

Evaluation Studies as Topic↗

Cluster-randomised trial of risk communication to enhance informed uptake of cervical screening.

BACKGROUND: Women overestimate both population and individual risk of cervical cancer. This may contribute to the recognised excess screening frequency for low-risk women. AIM: To investigate whether an individualized risk communication package could affect stated preferences for screening interval and actual screening behaviour. DESIGN: Pragmatic, practice-based cluster randomised controlled trial. SETTING: Twenty-nine practices (15 intervention, 14 control) in North Wales recruited 1890 women attending for cervical smears. METHOD: A risk communication package containing visual material was compared with normal practice. Practice nurses received training in its delivery. The short-term primary outcome was stated preference for screening interval; the long-term primary outcome was actual screening behaviour. RESULTS: In the short term, intervention arm women were significantly less likely to prefer a shorter than recommended interval (odds ratio [OR] = 0.51, 95% confidence interval [CI] = 0.41 to 0.64; P < 0.0001). At the five-year follow-up, fewer women in the intervention arm had attended for screening sooner than their recommended recall. The magnitude of difference in excess screening interval preference and behaviour was similar, but behaviour had a wider confidence interval and a marginally non-significant P-value (OR = 0.61, 95% CI = 0.36 to 1.03; P = 0.063). Better knowledge and more accurate risk perceptions were demonstrated, with an improvement in measures of anxiety. The extra cost per woman receiving the intervention was 6 Pounds. CONCLUSIONS: Women's perception of risk contributes to determining screening intervals in addition to practice factors. Simple risk information delivered in primary care affected women's stated preferences for tests. The impact on actual screening behaviour was more equivocal. Overall, the intervention showed a substantial benefit and any disbenefit can be ruled out. This approach to providing risk information could, at low cost, benefit other screening programmes and may relieve anxiety.

Adult↗

Would monolayers provide more representative samples and improved preparations for cervical screening? Overview and evaluation of systems available.

Conventional cervical smears prepared on site by the smear taker are subject to great variation in technical quality and allow little control of the critical parameters required for optimal microscopic diagnosis. More critical, however, is that a significant proportion of the cells removed from the cervix are discarded along with the collecting device and that the material placed on the slide is not transferred in a representative way and may not fully represent the cells removed from the cervix. If the cells were placed directly into preservative fluid, all the material scraped from the cervix would be sent to the laboratory in a well-preserved state, and fully representative slides could be prepared. Several studies have suggested that this would result in an increased cell harvest with a reduction of inadequate slides and an increase in the detection of abnormal cells. Automated preparation devices are now available. Two such devices, CytoRich and ThinPrep, were recently evaluated at the University of Edinburgh Department of Pathology (UEPD). The operational characteristics of each device were evaluated and consumables costed according to 1993-1994 prices. The consumables for the CytoRich were calculated to be more expensive, while operator time for the ThinPrep was more expensive. More mechanical problems were encountered with the ThinPrep, which was also considered more tedious to use. Cytotechnologists required considerable retraining before reaching competence in screening monolayers. They could assess them in approximately half the time required for conventional smears but found it more tiring. Almost no monolayer slides were considered unsatisfactory for laboratory interpretation due to the cells' being obscured by blood, pus or thick streaks of other cells. Scanty monolayers proved particularly difficult to read and interpret. Despite the bias introduced by using only the "leftover" material to make the monolayer, the diagnostic results of the monolayers from both devices were broadly similar to those for the matched split sample conventional smears. UEPD concluded that both devices produced monolayers that were adequate for diagnostic purposes. Neither device was ideal for routine laboratory use in cervical cytopathology in the model tested by UEPD, but both companies recently modified their devices in the light of the deficiencies identified by UEPD. The substantial loss of potentially diagnostic cells during the conventional transfer of cervical scrape material to glass slide alone merits consideration of alternative methods of preparation to obtain representative cell samples for optimal conventional microscopic diagnosis. Monolayers prepared by automated devices offer such an improvement for routine cervical cytopathology. The general deployment of such machines (involving substantial changes in the methods of working of laboratory staff responsible for tens of thousands of clinically important decisions each year) must await the completion of extensive and exhaustive laboratory and field trials. It is recommended that such trials be designed so that all the cellular material removed from the cervix is placed in the cell suspension, and the assessments should be carried out in a routine laboratory environment by cytotechnologists working in a routine cervical cytopathology service.

Evaluation Studies as Topic↗

Is a policy of cervical screening for all women attending a genito-urinary medicine clinic justified?

BACKGROUND: The study took place at the Genito-Urinary Medicine Department at the University Hospital of South Manchester and the Cytology Department at Christie NHS Trust Hospital. There were two main objectives, as follows: (1) to determine if patients attending a Genito-Urinary Medicine (GUM) Clinic are less likely to have had a cervical smear in the preceding five years than a control group drawn from the general population; (2) to compare the prevalence of cytological abnormalitity in cases and controls. METHODS: Cases comprised all women attending the Withington GUM Clinic, between 1991 and 1993, who had had a cervical smear taken at this clinic. Controls were selected from residents of the North West Regional Health Authority who had a cervical smear taken either by a general practitioner (GP) or in an NHS Community Clinic during the same period. The design was a matched case-control study. The main outcome measures considered the proportion of women who had had a cervical smear taken by a GP or in an NHS Community Clinic during the five years preceding the index smear, and the prevalence of abnormal smears in cases and controls. RESULTS: There was no significant difference in the screening history of cases and controls; 363 (50.2 per cent) cases had had a cervical smear taken in the preceding five years as compared with 380 (52.6 per cent) controls [chi 2 (1df) = 0.95; p > 0.05; 95 per cent confidence interval (CI) on difference in proportions, -7.1 per cent to 2.4 per cent]. There was a small case-control difference of borderline significance in the prevalence of all grades of cytological abnormality: 22.7 per cent of cases had abnormal cytology as compared with 18.5 per cent of controls [chi 2 (1df) = 3.98; 0.01 < p < 0.05; 95 per cent CI on difference in proportions, 1 per cent to 8.2 per cent). This excess was largely attributable to differences in the prevalence of minor cytological abnormality. There was no significant difference in the prevalence of cytological abnormality in those case-control pairs who had had a smear in the preceding five years. CONCLUSION: A policy of cervical screening of all GUM patients can no longer be sustained. We would recommend cervical cytology only for those women who have not been screened in the previous three to five years.

Adolescent↗

Cervical screening in elderly women in Singapore.

The study was conducted to determine the pick-up rate of abnormal cervical smears and the prevalence rate of cervical cancer in women aged 60 years and above and the demographic characteristics of the women screened. The pick-up rate of abnormal cervical smears was 1.65%. The prevalence rate for cervical intraepithelial neoplasia and frank carcinoma was 6.4 and 5.0 per thousand women screened respectively. The study group comprised 89.7% Chinese, 4.7% Malays, 3.6% Indians and 2.0% Others. The pick-up rate of abnormal smears was 1.9% in the Chinese and 1.3% in the Indians. There were no abnormal smears in the Malays and Others. The results demonstrate the importance of a routine cervical cancer screening programme among elderly women aged 60 years and above in Singapore.

Age Factors↗

Optimising the age, number of tests, and test interval for cervical screening in Canada.

Different approaches to screening for cancer of the cervix by cervical cytology have been evaluated using a computer simulation model developed by Knox and data on the natural history of carcinoma-in-situ (or worse) from a cohort study of women screened in British Columbia, 1949-69. The natural history input parameters and the output parameters without screening were modified to reflect the earlier onset of carcinoma-in-situ in younger cohorts now being experienced in British Columbia, resulting in simulated mortality from carcinoma of the cervix approximately 50% greater than that experienced in Canada in 1955. The simulations showed that the sensitivity of the test and the proportion of women in the population who accept invitations to attend for screening materially influence the extent to which programmes reduce mortality. Missed screens also have an important impact. With a 75% test sensitivity, and an 80% population acceptance, a programme designed to reduce mortality by 90% would commence at age 25, involve triennial screens to age 52, or triennial screens to age 40 and quinquennial screens to age 60, a total of 10 tests in a lifetime. A repeat test at age 26 contributes nothing to the mortality benefit. Nevertheless, additional modifications of the natural history specifications to accommodate high-risk younger women would require a more frequent schedule of examinations under the age of 35, though at a substantial 'cost' in terms of the total number of examinations required in a population.

Adolescent↗